Research and Markets has announced the addition of the "Venous Thromboembolism Treatment Market - Forecast (2016-2022)" report to their offering.

Globally, the development of efficient and advanced technology, rise in the awareness among people regarding existing treatments for venous thromboembolism, increasing government initiatives across the globe, growing prevalence and incidence rate of venous thromboembolism are the prime growth drivers of the venous thromboembolism treatment market.

In addition, an increase in adoption of venous thromboembolism treatment in emerging economies such as China, India and others, will create new opportunities for the venous thromboembolism treatment market. However, higher cost of the research and development, and complex government regulatory approvals are the key restraints for the venous thromboembolism treatment market.

Geographically, North America dominated the venous thromboembolism treatment market, because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the types, deep vein thrombosis (DVT) has the highest market share in the venous thromboembolism treatment market.

Companies Mentioned:

  • Abbott Laboratories
  • Bio Compression Systems, Inc.
  • Boehringer Ingelheim GmbH
  • Upsher-Smith Laboratories,Inc
  • Bristol-Myers Squibb Company
  • Merck & Co.
  • Dupont Pharm Co
  • Wockhardt Ltd
  • Bayer AG
  • Pfizer Inc.

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Venous Thromboembolism Treatment Market, By Type

7. Venous Thromboembolism Treatment Market, By Treatment

8. Venous Thromboembolism Treatment Market, By Geography

9. Market Entropy

10. Company Profiles

11. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/t4hf52/venous